Novartis Pharma Ag

Rediff.com » News » Novartis Pharma Ag

News for Novartis Pharma Ag

Business

Novartis to focus on alliances

The $25 billion Novartis AG has identified 'alliance model' as its growth strategy in India. The Swiss drug maker is exploring collaborations with Indian pharmaceutical companies in all possible......

Cipla appoints Subhanu Saxena as new CEO

Drug-maker Cipla today said it has appointed Subhanu Saxena as the chief executive officer of the company.The appointment is effective from February 1, 2013.Saxena has more than 25 years of work......

'Novartis case: SC ruling wise and balanced'

The Supreme Court recently rejected the plea of Novartis AG for patent protection of its anti-cancer drug Glivec.The Supreme Court judgement (pages 22 -26) quite extensively quoted from Sudip......

Govt refutes Novartis' allegations on patents

Tearing into the allegations made by Novartis on India's 'discriminatory' patent practices, the government has said global firms, including the Swiss drug major, have benefited more from the......

SC denies patent to Novartis's cancer drug Glivec

Swiss pharma major Novartis AG on Monday lost a seven-year long legal battle for getting its blood cancer drug Glivec patented in India and to restrain Indian companies from manufacturing generic......

Novartis Pharma Ag

News for Novartis Pharma Ag

Novartis to focus on alliances

Cipla appoints Subhanu Saxena as new CEO

'Novartis case: SC ruling wise and balanced'

Govt refutes Novartis' allegations on patents

SC denies patent to Novartis's cancer drug Glivec

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS